tiprankstipranks
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market
Holding LTRN?
Track your performance easily

Lantern Pharma (LTRN) Stock Investors

241 Followers
Based on 768,258 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LTRN
On average, investors allocate 0.00% of their portfolios to LTRN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 768,258 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LTRN

2.0%
Last 7
Days
6.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LTRN, out of 768,258 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LTRN Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,679 investors who made their portfolios public
The table shows changes in LTRN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LTRN Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.47%
-1.79%
+0.46%
35.08B
Consumer Cyclical
Plug Power
5.21%
-1.12%
-0.73%
1.70B
Industrials
Bristol-Myers Squibb
3.56%
-0.64%
-1.29%
114.02B
Healthcare
Marathon Digital Holdings
5.64%
+0.76%
+5.08%
6.78B
Financial
Lucid Group
5.80%
-0.24%
+2.31%
6.05B
Consumer Cyclical
Block
4.47%
+1.52%
+3.74%
51.87B
Technology
Riot Platforms
5.30%
+0.10%
+2.02%
4.11B
Financial
Lam Research
3.50%
+1.24%
+5.03%
90.13B
Technology
Viking Therapeutics
4.54%
-0.83%
+5.78%
5.53B
Healthcare
Trade Desk
4.78%
-0.93%
+1.51%
58.32B
Technology
Based on the activity of 768,258 active portfolios
Open your Smart Portfolio

LTRN Investor Analysis

LTRN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.5%
of LTRN holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
LTRN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
52.4%
of LTRN holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
LTRN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
38.1%
of LTRN holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of LTRN stock investors
See who invests in LTRN according to age group and performance.

FAQ

How many retail Investors hold LTRN?
<0.1% of TipRanks' retail investors hold LTRN in their portfolios.
    What is LTRN Investor Sentiment?
    LTRN’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of LTRN in the last 7 days?
      ▼ 2.0% of TipRanks' retail investors changed their holding of LTRN in the last 7 days.
        What percentage of retail investors changed their holding of LTRN in the last 30 days?
        ▼ 6.0% of TipRanks' retail investors changed their holding of LTRN in the last 30 days.
          What is the average age of retail investors who hold LTRN?
          The average age of LTRN Holders is between 35–55.
            What other stocks have LTRN investors also bought?
            LTRN Investors also bought DKNG, PLUG, BMY, MARA, LCID, SQ, RIOT, LRCX, VKTX, TTD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BAXBaxter International
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis